Piper Sandler Reiterates Overweight Rating on Supernus Pharmaceuticals (SUPN)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/4/2026

1. PANW
2. SPY
3. ULTA
4. GTLB
5. USO
6. CRWD
7. GOOGL
8. MDT
9. AVGO
10. VRTS

Go back to Piper Sandler Reiterates Overweight Rating on Supernus Pharmaceuticals (SUPN)
SUPERNUS PHARM (NASDAQ: SUPN) Delayed: 44.04 -0.03 (0.07%)
Previous Close $44.07    52 Week High $26.84 
Open $43.93    52 Week Low $9.51 
Day High $44.98    P/E N/A 
Day Low $43.45    EPS $-2.62 
Volume 1,003,056